These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14562338)

  • 1. Improved chemical strategies for the targeted therapy of cancer.
    Maison W; Frangioni JV
    Angew Chem Int Ed Engl; 2003 Oct; 42(39):4726-8. PubMed ID: 14562338
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments in taxane drug delivery.
    Safavy A
    Curr Drug Deliv; 2008 Jan; 5(1):42-54. PubMed ID: 18220550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted taxane therapy for cancer.
    Whelan J
    Drug Discov Today; 2002 Jan; 7(2):90-2. PubMed ID: 11790612
    [No Abstract]   [Full Text] [Related]  

  • 4. A chemical adaptor system designed to link a tumor-targeting device with a prodrug and an enzymatic trigger.
    Gopin A; Pessah N; Shamis M; Rader C; Shabat D
    Angew Chem Int Ed Engl; 2003 Jan; 42(3):327-32. PubMed ID: 12548691
    [No Abstract]   [Full Text] [Related]  

  • 5. Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane.
    Fu Q; Lv P; Chen Z; Ni D; Zhang L; Yue H; Yue Z; Wei W; Ma G
    Nanoscale; 2015 Mar; 7(9):4020-30. PubMed ID: 25653083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers in cancer clinical practice: a pharmacokinetic issue.
    Giodini L; Re FL; Campagnol D; Marangon E; Posocco B; Dreussi E; Toffoli G
    Nanomedicine; 2017 Feb; 13(2):583-599. PubMed ID: 27520727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 1.
    Walker K; Kibble A; Shumoogam J
    IDrugs; 2007 Aug; 10(8):513-6. PubMed ID: 17665320
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
    Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
    J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-targeting strategies in cancer therapy.
    Huang PS; Oliff A
    Curr Opin Genet Dev; 2001 Feb; 11(1):104-10. PubMed ID: 11163159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 12,13-isotaxanes: synthesis of new potent analogs and X-ray crystallographic confirmation of structure.
    Johnson RA; Dobrowolski PJ; Nidy EG; Gebhard I; Qualls SJ; Wicnienski NA; Kelly RC; Pitts TW; Lopes NM; DeKoning TF; Mattern SJ; Weed SD; McGovren JP; Chidester CG
    J Med Chem; 1997 Aug; 40(18):2810-2. PubMed ID: 9288161
    [No Abstract]   [Full Text] [Related]  

  • 12. Paclitaxel prodrugs: toward smarter delivery of anticancer agents.
    Skwarczynski M; Hayashi Y; Kiso Y
    J Med Chem; 2006 Dec; 49(25):7253-69. PubMed ID: 17149855
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of irreversible cardiomyopathy induced by polychemotherapy].
    Skopets IS; Vezikova NN; Ivanova EP; Sergeeva SS; Ignatenko OV
    Ter Arkh; 2015; 87(12):73-76. PubMed ID: 26978422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine-rich CPPs for improved drug delivery to tumors.
    Park K
    J Control Release; 2012 Apr; 159(2):153. PubMed ID: 22578245
    [No Abstract]   [Full Text] [Related]  

  • 15. Macromolecules as taxane delivery systems.
    Dosio F; Stella B; Arpicco S; Cattel L
    Expert Opin Drug Deliv; 2011 Jan; 8(1):33-55. PubMed ID: 21142695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.
    Kouchakzadeh H; Safavi MS; Shojaosadati SA
    Adv Protein Chem Struct Biol; 2015; 98():121-43. PubMed ID: 25819278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate.
    Miller K; Erez R; Segal E; Shabat D; Satchi-Fainaro R
    Angew Chem Int Ed Engl; 2009; 48(16):2949-54. PubMed ID: 19294707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal chemistry and chemical biology of new generation taxane antitumor agents.
    Ojima I; Geney R; Ungureanu IM; Li D
    IUBMB Life; 2002; 53(4-5):269-74. PubMed ID: 12121008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel targeting drug carrier to deliver chemical bonded and physical entrapped anti-tumor drugs.
    Huang L; Song J; Chen B
    Int J Pharm; 2014 May; 466(1-2):52-7. PubMed ID: 24607212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro.
    Sawant RM; Cohen MB; Torchilin VP; Rokhlin OW
    J Drug Target; 2008 Aug; 16(7):601-4. PubMed ID: 18686131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.